Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Buy
65
PFX Quote, Financials, Valuation and Earnings
Last price:
$53.00
Seasonality move
:
7.82%
Day range:
$53.31 - $53.31
52-week range:
$42.50 - $57.40
Dividend yield:
0%
P/E ratio:
6.54x
P/S ratio:
4.14x
P/B ratio:
0.66x
Volume:
2K
Avg. volume:
3.1K
1-year change:
20.97%
Market cap:
$107.7M
Revenue:
$28.6M
EPS (TTM):
$8.15
Analysts' Opinion
-
Consensus RatingPhenixFIN has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, PhenixFIN has an estimated downside of -34.35% from its current price of $53.31.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $53.31.
Fair Value
-
According to the consensus of 1 analyst, PhenixFIN has -34.35% downside to fair value with a price target of -- per share.
PFX vs. S&P 500
-
Over the past 5 trading days, PhenixFIN has underperformed the S&P 500 by -1.15% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
PhenixFIN does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
PhenixFIN revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter PhenixFIN reported revenues of $4.5M.
Earnings Growth
-
PhenixFIN earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter PhenixFIN reported earnings per share of $1.22.
Enterprise value:
242.2M
EV / Invested capital:
0.80x
Price / LTM sales:
4.14x
EV / EBIT:
10.41x
EV / Revenue:
9.29x
PEG ratio (5yr expected):
0.15x
EV / Free cash flow:
-4.26x
Price / Operating cash flow:
6.21x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
6.15%
Net Income Margin (TTM):
63.47%
Return On Equity:
10.58%
Return On Invested Capital:
6.3%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $417.4K | $36.2M | $26.1M | $7M | $4.5M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$3.09 | $13.18 | $8.15 | $2.19 | $1.22 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $62.8M | $64M | $20.7M | $14.4M | $9.8M | |
| Total Assets | $224M | $240.7M | $205.4M | $237.8M | $311.9M | |
| Current Liabilities | $2.5M | $13.5M | $1.6M | $2.4M | $7.2M | |
| Total Liabilities | $79.8M | $92.2M | $80.7M | $87.1M | $149.2M | |
| Total Equity | $144.2M | $148.5M | $124.7M | $150.7M | $162.8M | |
| Total Debt | $77.2M | $77.6M | $78.1M | $84.3M | $141.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$24.1M | -$9.3M | -$56.9M | $6.8M | -$66.3M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -$17.7M | $3.8M | $51.9M | -$568.6K | $5.9M | |
| Free Cash Flow | -$24.1M | -$9.3M | -$56.9M | $6.8M | -$66.3M | |
PFX
Sector
Market Cap
$107.7M
$625.8M
Price % of 52-Week High
92.88%
86.55%
Dividend Yield
0%
1.95%
Shareholder Yield
-6.86%
3.76%
1-Year Price Total Return
20.97%
9.43%
Beta (5-Year)
0.874
0.712
Dividend yield:
0%
Annualized payout:
$1.31
Payout ratio:
15.99%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$53.43
200-day SMA
Buy
Level
$48.35
Bollinger Bands (100)
Buy
Level
47.22 - 52.04
Chaikin Money Flow
Sell
Level
-186.8K
20-day SMA
Sell
Level
$53.51
Relative Strength Index (RSI14)
Buy
Level
54.78
ADX Line
Buy
Level
18.1
Williams %R
Neutral
Level
-60.2801
50-day SMA
Buy
Level
$51.20
MACD (12, 26)
Buy
Level
0.57
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Sell
Level
-46.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.4933)
Buy
CA Score
(Annual)
Level (0.283)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (0.5122)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
Stock Forecast FAQ
In the current month, PFX has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The PFX average analyst price target in the past 3 months is --.
-
Where Will PhenixFIN Stock Be In 1 Year?
According to analysts, the consensus estimate is that PhenixFIN share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About PhenixFIN?
Analysts are divided on their view about PhenixFIN share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PhenixFIN is a Sell and believe this share price will rise from its current level to --.
-
What Is PhenixFIN's Price Target?
The price target for PhenixFIN over the next 1-year time period is forecast to be -- according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is PFX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for PhenixFIN is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of PFX?
You can purchase shares of PhenixFIN via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PhenixFIN shares.
-
What Is The PhenixFIN Share Price Today?
PhenixFIN was last trading at $53.00 per share. This represents the most recent stock quote for PhenixFIN. Yesterday, PhenixFIN closed at $53.31 per share.
-
How To Buy PhenixFIN Stock Online?
In order to purchase PhenixFIN stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
